Factors associated with health-related quality of life in multiple sclerosis

Canadian Journal of Neurological Sciences

Volumn 34, Issue 2, 2007, Pages 160-166

  Hopman, Wilma M ^a,b   Coo, Helen ^b   Edgar, Cathy M ^a   McBride, Evelyn V ^a   Day, Andrew G ^a,b   Brunet, Donald G ^a,b  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; AGED; ARTICLE; COST OF ILLNESS; DEPRESSION; DISEASE DURATION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE; MULTIPLE SCLEROSIS QUALITY OF LIFE INVENTORY; NON INVASIVE MEASUREMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36;

EID: 34347262396     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005989     Document Type: Article

References (27)

1. The Canadian Burden of Illness Study Group. Burden of illness in multiple sclerosis: Part I: Cost of illness. Can J Neuro Sci. 1998;25:23-30.
2. Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, Li TT. Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler. 2005;11:232-9.
3. Grima DT, Torrance GW, Francis G, Rice G, Rosner AJ, Lafortune L. Cost and health-related quality of life consequences of multiple sclerosis. Mult Scler. 2000;6:91-8.
4. The Canadian Burden of Illness Study Group. Burden of illness in multiple sclerosis: Part II: Quality of Life. Can J Neuro Sci. 1998;25:31-38.
5. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neuro Sci. 1996;23:99-103.
6. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology. 1997;48:74-80.
7. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004;61:679-86.
8. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1988;33:1444-52.
9. Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients, J Neurol Sci. 2003;211:55-62.
10. Ware JE Jr, Snow KK, Kosinski M. SF-36 health survey: manual & interpretation guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.
11. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user manual and interpretation guide. Boston MA Health Institute; 1994.
12. Singer MA, Hopman WM, MacKenzie TA. Psychological adjustment in four chronic medical conditions. Qual Life Res. 1999;8:687-91.
13. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. Multiple sclerosis quality of life inventory: a user's manual. New York: National Multiple Sclerosis Society; 1997.
14. Hopman WM, Coo H, Brunet DG, Edgar CM, Singer MA. Longitudinal assessment of health-related quality of life (HRQOL) of patients with multiple sclerosis. International J MS Care. 2000;2:15-26.
15. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease-targeted health-related quality-of-life measure for multiple sclerosis. J Clin Epid. 1997;50:557-69.
16. Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol. 2000;57:1319-24.
17. Sullivan JJL, Edgeley K, Dehoux E. A survey of multiple sclerosis. Part 1: perceived cognitive problems and compensatory strategy use. Can J Rehab. 1990;4:99-105.
18. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5:244-50.
19. Coo H, Hopman WM, Edgar CM, McBride EV, Brunet DG. The paced auditory serial addition test: to what extent is it performed as instructed, and is it associated with disease course? Mult Scler. 2005;11:85-9.
20. Fischer JS, Jak AJ, Knicker JE, Rudick RA, Cutter G. Administration and scoring manual for the Multiple Sclerosis Functional Composite Measure. New York, New York: National Multiple Sclerosis Society; Revised 2001.
21. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, et al. Canadian normative data for the SF-36 health survey. CMAJ. 2000; 163:265-71.
22. Janardhan V, Nakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002;15:51-8.
23. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110:6-13.
24. McCabew MP, De Judicibus M. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis. J Health Psyc. 2005;10:163-73.
25. Williams RM, Turner AP, Hatzakis M Jr, Bowen JD, Rodriques AA, Hasselkorn JK. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology. 2005;64:75-80.
26. Jiang Y, Hesser JE. Associations between health-related quality of life and demographics and health risks. Results from Rhode Island's 2002 Behavioural Risk Factor Survey. Health Qual Life Outcomes. 2006;3:14 (Epub ahead of print).
27. Miller A, Dishon S. Health-related quality of life in Multiple Sclerosis: the impact of disability, gender and employment status. Qual Life Res. 2006;15:259-71.